Kissei
http://dbpedia.org/resource/Kissei an entity of type: Thing
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.
rdf:langString
キッセイ薬品工業株式会社（キッセイやくひんこうぎょう）は、長野県松本市芳野に本社を置く医薬品メーカーである。
rdf:langString
rdf:langString
Kissei
rdf:langString
キッセイ薬品工業
rdf:langString
Kissei Pharmaceutical
rdf:langString
Kissei Pharmaceutical
xsd:integer
62730357
xsd:integer
1036200361
xsd:date
1946-08-09
rdf:langString
Japan
rdf:langString
Pharmaceutical products, therapeutic and care foods
rdf:langString
Mutsuo Kanzawa
xsd:integer
1504
rdf:langString
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
* Difelikefalin
* Fostamatinib (trade name Tavalisse)
* Linzagolix
* Mitiglinide (Glufast)
* Remogliflozin etabonate
* Silodosin (Urief)
* Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.
rdf:langString
キッセイ薬品工業株式会社（キッセイやくひんこうぎょう）は、長野県松本市芳野に本社を置く医薬品メーカーである。
rdf:langString
JP3240600001
xsd:nonNegativeInteger
2056
xsd:date
1946-08-09
xsd:gYear
1946
xsd:nonNegativeInteger
1504